newsfilter
← Latest News
PR Newswire·

Compugen Reports Third Quarter 2024 Results

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...